去甲肾上腺素与特利加压素联合使用与单独使用去甲肾上腺素治疗感染性休克的比较：顾虑较少。
Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns.
作者信息
Khera Daisy, Suresh Chethan
机构信息
Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
出版信息
Indian J Crit Care Med. 2023 Aug;27(8):605. doi: 10.5005/jp-journals-10071-24503.
Abstract
: Khera D, Suresh C. Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns. Indian J Crit Care Med 2023;27(8):605.
摘要
凯拉·D、苏雷什·C。去甲肾上腺素与特利加压素联合去甲肾上腺素治疗感染性休克的比较：一些问题。《印度重症监护医学杂志》2023年；27(8):605。
相似文献
1
Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns.去甲肾上腺素与特利加压素联合使用与单独使用去甲肾上腺素治疗感染性休克的比较：顾虑较少。
Indian J Crit Care Med. 2023 Aug;27(8):605. doi: 10.5005/jp-journals-10071-24503.
2
Author Reply: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study.作者回复：去甲肾上腺素与特利加压素联合去甲肾上腺素治疗感染性休克的比较：一项随机对照研究。
Indian J Crit Care Med. 2023 Aug;27(8):603-604. doi: 10.5005/jp-journals-10071-24514.
3
Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study.去甲肾上腺素与特利加压素联用与单用去甲肾上腺素治疗感染性休克的比较：一项随机对照研究。
Indian J Crit Care Med. 2022 Jun;26(6):669-675. doi: 10.5005/jp-journals-10071-24231.
4
[Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial].去甲肾上腺素与特利加压素对急性呼吸窘迫综合征合并感染性休克患者疗效的比较：一项前瞻性单盲随机对照试验
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Feb;29(2):111-116. doi: 10.3760/cma.j.issn.2095-4352.2017.02.004.
5
Vasopressors in Septic Shock: The Quest for Refinement.脓毒性休克中的血管升压药：追求优化
Indian J Crit Care Med. 2022 Jun;26(6):659-660. doi: 10.5005/jp-journals-10071-24248.
6
Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study.特利加压素联合去甲肾上腺素治疗感染性休克及对肾灌注的影响：一项初步研究。
Ren Fail. 2022 Dec;44(1):1207-1215. doi: 10.1080/0886022X.2022.2095286.
7
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.连续特利加压素与血管加压素输注治疗感染性休克（TERLIVAP）：一项随机对照的初步研究。
Crit Care. 2009;13(4):R130. doi: 10.1186/cc7990. Epub 2009 Aug 10.
8
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.特利加压素与去甲肾上腺素治疗感染性休克患者的比较：一项多中心、随机、双盲试验。
Intensive Care Med. 2018 Nov;44(11):1816-1825. doi: 10.1007/s00134-018-5267-9. Epub 2018 Jul 3.
9
Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock.比较一线和二线特利加压素与单纯去甲肾上腺素治疗暴发性绵羊感染性休克的疗效。
Sci Rep. 2018 May 8;8(1):7105. doi: 10.1038/s41598-018-25570-x.
10
Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.特利加压素与去甲肾上腺素治疗高动力型感染性休克的前瞻性随机研究
Crit Care Med. 2005 Sep;33(9):1897-902. doi: 10.1097/01.ccm.0000178182.37639.d6.
本文引用的文献
1
Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study.去甲肾上腺素与特利加压素联用与单用去甲肾上腺素治疗感染性休克的比较：一项随机对照研究。
Indian J Crit Care Med. 2022 Jun;26(6):669-675. doi: 10.5005/jp-journals-10071-24231.
2
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动：2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
3
Cardiovascular determinants of resuscitation from sepsis and septic shock.从脓毒症和感染性休克中复苏的心血管决定因素。
Crit Care. 2019 Apr 15;23(1):118. doi: 10.1186/s13054-019-2414-9.
4
Early goal-directed therapy for severe sepsis and septic shock: A living systematic review.严重脓毒症和脓毒性休克的早期目标导向治疗：一项动态系统评价
J Crit Care. 2016 Dec;36:43-48. doi: 10.1016/j.jcrc.2016.06.017. Epub 2016 Jun 29.
5
Odds ratio vs risk ratio in randomized controlled trials.随机对照试验中的比值比与风险比
Postgrad Med. 2015 May;127(4):359-67. doi: 10.1080/00325481.2015.1022494. Epub 2015 Mar 7.
Zotero 插件